Needham Maintains Buy on Pulse Biosciences, Raises Price Target to $64
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsPrice Target
Needham analyst Mike Matson maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $64.
Needham analyst Mike Matson maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $64.